Cellular and Molecular Mechanisms Underlying Glioblastoma and Zebrafish Models for the Discovery of New Treatments

Glioblastoma (GBM) is the most common of all brain malignant tumors; it displays a median survival of 14.6 months with current complete standard treatment. High heterogeneity, aggressive and invasive behavior, the impossibility of completing tumor resection, limitations for drug administration and t...

Full description

Bibliographic Details
Main Authors: Pedro Reimunde, Alba Pensado-López, Martín Carreira Crende, Vanesa Lombao Iglesias, Laura Sánchez, Marta Torrecilla-Parra, Cristina M. Ramírez, Clément Anfray, Fernando Torres Andón
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/5/1087